Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)
Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8